Establishing an accurate diagnosis and classification of haematological malignancies (blood cancers) relies on a spectrum of molecular diagnostic tests to evaluate chromosomal and nucleotide ...
Objective: Patients receiving cancer treatments commonly experience haematological adverse effects (AEs) related to chemotherapy or molecularly targeted therapies, which may be associated with ...